{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:25:06Z","timestamp":1793985906645,"version":"4.8.0"},"reference-count":63,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Expectations"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to explore the impact of shielding amongst immunocompromised individuals following the COVID\u201019 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This study used a cross\u2010sectional exploratory qualitative design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A national survey was launched in July 2023 aiming to collect information on the lived experience of individuals who were still shielding. The final question to this study was \u2018what has been the worst aspect of shielding for you?\u2019. In total, 457 individuals (57%) responded to this question. Data were analysed using thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three themes were identified, associated with the impact of shielding:<\/jats:p>\n                    <jats:p>(1) Navigating risk: including fear of infection, distrust in institutional guidance and measures.<\/jats:p>\n                    <jats:p>(2) Loss and longing: including profound isolation, grieving lost time, loss of freedom and relationships.<\/jats:p>\n                    <jats:p>(3) Betrayed and forsaken: a sense of intentional abandonment by government and lack of understanding from loved ones, causing distress and mistrust.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings from this study indicate that individuals who are shielding continue to experience profound difficulties that require attention. Measures must be introduced to mitigate the impact of COVID in the immunocompromised, including improving public health messaging and strategies to tackle isolation. Given the high likelihood of future pandemics, it is imperative that strategies are developed to address the needs of its most vulnerable populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient or Public Contribution<\/jats:title>\n                    <jats:p>Patient and public contribution has formed an integral part in the assignment of this study. The rationale and design of this study was created in partnership with Forgotten Lives UK and the National Clinical Expert Group, who represent 125 clinicians, across 4 nations and 17 medical specialities treating immunocompromised patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hex.70675","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:49:08Z","timestamp":1776408548000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the Psychological Impacts of Shielding From COVID\u201019 for Immunocompromised Individuals"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0546-6822","authenticated-orcid":false,"given":"Anna","family":"Gray","sequence":"first","affiliation":[{"name":"Department of Psychology University of Bath Bath UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-0863","authenticated-orcid":false,"given":"Julie","family":"Barnett","sequence":"additional","affiliation":[{"name":"Department of Psychology University of Bath Bath UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-9990","authenticated-orcid":false,"given":"Luca","family":"Bernardi","sequence":"additional","affiliation":[{"name":"Department of Politics University of Liverpool Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3067-9416","authenticated-orcid":false,"given":"Jo","family":"Daniels","sequence":"additional","affiliation":[{"name":"Department of Psychology University of Bath Bath UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30308-4"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1198"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073464"},{"key":"e_1_2_13_5_1","unstructured":"Department of Health and Social Care COVID\u201019: Guidance for People Whose Immune System Means They Are at Higher Risk(GOV.UK. 2021) https:\/\/www.gov.uk\/government\/publications\/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk."},{"key":"e_1_2_13_6_1","unstructured":"NHS England Information About the End of the Shielding Programme and Managing the Closure of the Shielded Patient List(NHS England 2021) https:\/\/www.england.nhs.uk\/coronavirus\/documents\/information-about-the-end-of-the-shielding-programme-and-managing-the-closure-of-the-shielded-patient-list\/."},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf074"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-024-03043-0"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03457-1"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02414-4"},{"key":"e_1_2_13_11_1","unstructured":"Forgotten Lives UK Still Shielding \u2013 The Mental Health of Immunocompromised Patients at Continued Risk of COVID\u201019(Forgotten Lives UK 2025) https:\/\/www.forgottenlives.uk\/still-shielding-the-mental-health-of-immunocompromised-patients-at-continued-risk-of-covid-19\/."},{"key":"e_1_2_13_12_1","unstructured":"Versus Arthritis COVID Shielding Voices: Understanding the Experience of People With Arthritis Who Shielded During the COVID\u201019 Pandemic (2023) https:\/\/www.arthritis-uk.org\/media\/dhgnv3c1\/covid-shielding-voices-report.pdf."},{"issue":"4","key":"e_1_2_13_13_1","first-page":"e232","article-title":"The Impact of Shielding During the COVID\u201019 Pandemic on Mental Health: Evidence From the English Longitudinal Study of Ageing","volume":"7","author":"Di Gessa G.","year":"2022","journal-title":"Lancet Public Health"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19127333"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.5114\/hpr.2021.107336"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236562"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2025.105736"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/03637759209376276"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/2150132721996898"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.32598\/hdq.10.4.611.1"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09681-7"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.923549"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10410236.2020.1847446"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.2196\/24053"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17228637"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20064940"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.13775"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-024-01596-x"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1352465809990580"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa072"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.13005"},{"key":"e_1_2_13_32_1","unstructured":"Global Preparedness Monitoring Board New Risks Raise Pandemic Threat on a Global Scale(Global Preparedness Monitoring Board 2024) https:\/\/www.gpmb.org\/news\/news\/item\/14-10-2024-new-risks-raise-pandemic-threat-on-a-global-scale."},{"key":"e_1_2_13_33_1","unstructured":"WHO WHO Launches New Initiative to Improve Pandemic Preparedness(WHO 2023) https:\/\/www.who.int\/news\/item\/26-04-2023-who-launches-new-initiative-to-improve-pandemic-preparedness."},{"key":"e_1_2_13_34_1","unstructured":"NHS England Pandemic Preparedness & Exercise Pegasus(NHS England 2025) https:\/\/www.england.nhs.uk\/long-read\/pandemic-preparedness-exercise-pegasus\/."},{"key":"e_1_2_13_35_1","unstructured":"UK Covid\u201019 Enquiry Module 1: The Resilience and Preparedness of the United Kingdom(UK Covid\u201019 Enquiry 2024) https:\/\/covid19.public-inquiry.uk\/wp-content\/uploads\/2024\/07\/18095012\/UK-Covid-19-Inquiry-Module-1-Full-Report.pdf."},{"key":"e_1_2_13_36_1","unstructured":"Parallel Parliament Vulnerable Groups to Pandemics APPG(Parallel Parliament 2024) https:\/\/www.parallelparliament.co.uk\/APPG\/vulnerable-groups-to-pandemics."},{"key":"e_1_2_13_37_1","unstructured":"L.BernardiandJ.Daniels Forsaken but Engaged: An Inquiry Into the Psychological Aspects of COVID\u201019 Mental Health and Political Engagement of Immunocompromised People(University of Liverpool & University of Bath 2023) https:\/\/doi.org\/10.17638\/03197663."},{"key":"e_1_2_13_38_1","unstructured":"L.BernardiandJ.Daniels \u201cImmunocompromised People Covid\u201019 Mental Health Political Attitudes \u201d unpublished manuscript 2026."},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/17437199.2022.2161594"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/17437270701207694"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/2159676X.2019.1628806"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/17482631.2020.1838041"},{"key":"e_1_2_13_43_1","unstructured":"Reuters UK PM's Former Adviser Confirms Johnson Said \u201clet the Bodies Pile High\u201d 2021 May 26 2021 https:\/\/www.reuters.com\/world\/uk\/uk-pms-former-adviser-confirms-johnson-said-let-bodies-pile-high-2021-05-26\/?utm_source=chatgpt.com."},{"key":"e_1_2_13_44_1","unstructured":"UK Health Security Agency COVID\u201019 Cases Per 100 000 Population in 7\u2010Day Period(UK Health Security Agency 2025) https:\/\/ukhsa-dashboard.data.gov.uk\/respiratory-viruses\/covid-19."},{"key":"e_1_2_13_45_1","unstructured":"Centers for Disease Control and Prevention Underlying Conditions and the Higher Risk for Severe COVID\u201019(Centers for Disease Control and Prevention 2025) https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html."},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1037\/hea0000875"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000710"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/brief-treatment\/mhg026"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2018.03.004"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1037\/prj0000554"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnu.2008.11.002"},{"key":"e_1_2_13_52_1","volume-title":"Cognitive Therapy of Depression","author":"Beck A. T.","year":"2024"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/casp.2724"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2009.07.003"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/10926771.2017.1322654"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.025"},{"key":"e_1_2_13_57_1","unstructured":"All\u2010Party Parliamentary Groupon Vulnerable Groups to Pandemics Still Shielding: A Report on the Mental Health Impacts of Immunocompromised Patients at Continued Risk of COVID\u201019(APPG 2025) https:\/\/www.parallelparliament.co.uk\/files\/appg_documents\/vulnerable-groups-to-pandemics\/APPG_VGP_Press_release_Mental_Health_FINAL.pdf."},{"key":"e_1_2_13_58_1","unstructured":"NICE Tixagevimab Plus Cilgavimab for Preventing COVID\u201019(NICE 2023) https:\/\/www.nice.org.uk\/guidance\/ta900."},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1037\/xlm0001448"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/16506078909455848"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.00758"},{"key":"e_1_2_13_62_1","unstructured":"Public Accounts Committee Central\u2010Command System Failed to Reach Around 800k Clinically Extremely Vulnerable People Before Hundreds of Thousands Added to Local Lists(UK Parliament 2021) https:\/\/committees.parliament.uk\/committee\/127\/public-accounts-committee\/news\/154620\/centralcommand-system-failed-to-reach-around-800k-clinically-extremely-vulnerable-people-before-hundreds-of-thousands-added-to-local-lists\/."},{"key":"e_1_2_13_63_1","unstructured":"Medicines and Healthcare Products Regulatory Agency Patient Involvement Strategy: An Assessment of Progress(GOV.UK 2025) https:\/\/www.gov.uk\/government\/publications\/patient-involvement-strategy-an-assessment-of-progress\/patient-involvement-strategy-an-assessment-of-progress."},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/13645579.2020.1805550"}],"container-title":["Health Expectations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hex.70675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hex.70675","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hex.70675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:37:25Z","timestamp":1793983045000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hex.70675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/hex.70675"],"URL":"https:\/\/doi.org\/10.1111\/hex.70675","archive":["Portico"],"relation":{},"ISSN":["1369-6513","1369-7625"],"issn-type":[{"value":"1369-6513","type":"print"},{"value":"1369-7625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70675"}}